Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease: A Randomized Clinical Trial

IMPORTANCE: Although the Canadian Treat-and-Extend Analysis Trial With Ranibizumab in Patients With Neovascular Age-Related Macular Disease (CANTREAT) reported herein and the Treat and Extend study provided data to show noninferiority of treat-and-extend (T&E) at 12 months, to date there are few...

Descripción completa

Detalles Bibliográficos
Autores principales: Kertes, Peter J., Galic, Ivan J., Greve, Mark, Williams, Geoff, Baker, Jason, Lahaie, Marcel, Sheidow, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990694/
https://www.ncbi.nlm.nih.gov/pubmed/31917441
http://dx.doi.org/10.1001/jamaophthalmol.2019.5540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990694/
https://www.ncbi.nlm.nih.gov/pubmed/31917441
http://dx.doi.org/10.1001/jamaophthalmol.2019.5540

Ejemplares similares